Miranda Collier

Miranda Collier is a Principal Scientist at BridgeBio, where responsibilities include leading scientific initiatives in the development of treatments for genetic diseases within a preclinical discovery incubator. Previously, Miranda held roles at Stanford University as a Lead Scientist and Postdoctoral Fellow, focusing on protein quality control, quantitative cell biology, and mass spectrometry. Earlier experience includes a position as a Business Development Assistant at OMass Therapeutics, where marketing materials for native mass spectrometry applications were developed, and as a Teaching Assistant at the University of Alabama at Birmingham, instructing introductory chemistry labs. Miranda earned a PhD in Physical and Theoretical Chemistry from the University of Oxford and a Bachelor of Science in Chemistry from the University of Alabama at Birmingham.